Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$160.42 - $256.21 $59,515 - $95,053
-371 Reduced 4.9%
7,200 $1.35 Million
Q2 2022

Aug 15, 2022

SELL
$140.68 - $188.02 $195,404 - $261,159
-1,389 Reduced 15.5%
7,571 $1.23 Million
Q1 2022

May 16, 2022

SELL
$161.19 - $257.96 $800,953 - $1.28 Million
-4,969 Reduced 35.67%
8,960 $1.69 Million
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $760,348 - $935,027
-3,071 Reduced 18.06%
13,929 $3.69 Million
Q3 2021

Nov 15, 2021

SELL
$194.77 - $324.21 $665,529 - $1.11 Million
-3,417 Reduced 16.74%
17,000 $4.91 Million
Q2 2021

Aug 16, 2021

SELL
$165.87 - $220.95 $111,630 - $148,699
-673 Reduced 3.19%
20,417 $4.08 Million
Q1 2021

May 14, 2021

BUY
$180.37 - $226.26 $106,418 - $133,493
590 Added 2.88%
21,090 $4.1 Million
Q4 2020

Feb 16, 2021

BUY
$148.08 - $206.57 $484,369 - $675,690
3,271 Added 18.99%
20,500 $3.93 Million
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $23,399 - $30,229
191 Added 1.12%
17,229 $2.54 Million
Q2 2020

Aug 14, 2020

SELL
$94.33 - $140.48 $192,527 - $286,719
-2,041 Reduced 10.7%
17,038 $2.11 Million
Q1 2020

May 15, 2020

BUY
$84.96 - $109.14 $346,551 - $445,182
4,079 Added 27.19%
19,079 $1.84 Million
Q3 2019

Nov 14, 2019

BUY
$76.65 - $95.51 $45,990 - $57,306
600 Added 4.17%
15,000 $1.15 Million
Q2 2019

Aug 14, 2019

BUY
$54.2 - $85.95 $590,780 - $936,855
10,900 Added 311.43%
14,400 $1.24 Million
Q1 2019

May 15, 2019

BUY
$49.45 - $62.8 $173,075 - $219,800
3,500 New
3,500 $207,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.61B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.